Abstract:Background: The use of trans anastomotic feeding tube (TAFT) during the repair of Esophageal atresia/Tracheo-esophageal fistula (EA/TEF) aims to enhance outcomes by enabling early feeding, reducing the requirement for parenteral nutrition, and reducing complications such as anastomotic leak by stenting the anastomosis. However, TAFT's benefits and drawbacks are debated due to conflicting reports. Thus, we conducted a prospective pilot randomized control trial to elucidate the impact of TAFT on postoperative outcomes and the potential benefits of avoidance of TAFT. Methods: We performed a single-center randomized controlled trial in 53 neonates diagnosed with Type C EA/TEF who were operated on from January 2022 to June 2023. The patients were randomized into TAFT (n = 30) and non-TAFT (n = 23) groups. The patients were followed up for a minimum of 6 months following discharge. The primary objective of the study was to compare the rate of anastomotic leaks following primary repair of EA/TEF in both groups. Secondary objectives included early postoperative outcomes such as the occurrence of anastomotic stricture, time taken to initiate feeding, the time required to reach full feeding, the incidence of brief resolved unexplained events (BRUE) or acute life-threatening events (ALTE), the incidence of gastroesophageal reflux (GER), somatic growth, and all-cause mortality within 30 days post-surgery. Result: The study demonstrated that TAFT placement was associated with a higher incidence of anastomotic leaks (20 % vs 0, p = 0.03). However, there was no difference in the 30-day mortality between both groups. Although the rate of anastomotic strictures and GER was higher in the TAFT group (54.5 % vs 27.8 %, p = 0.08 and 25 % vs 57.1 %, p = 0.076), it did not reach statistical significance. Avoiding TAFT resulted in earlier initiation of enteral feeding (18 vs 22 days, p = 0.002), shorter time to achieve full feeds (15 vs 21 days, p = 0.03), reduced duration of TPN (3 vs 10 days; p = 0.001), improved weight gain at the 2-week follow-up (27.5 vs. 24.4 g/kg/day, p-value = 0.037) and lesser incidence of ALTE/BRUE (11.1 % vs 48 %, p = 0.01) at 6 months. Conclusion: While previous research has covered TAFT's impact on complications such as anastomotic leak, stricture, use of TPN and enteral feed, prospective randomized studies remain limited, and the impact on GER, somatic growth, and occurrence of ALTE/BRUE is still unexplored. This study evaluated the short-term outcomes of EA/TEF in a resource-challenged setting, shedding light on the potential benefits of repair without TAFT such as reduction in the rate of anastomotic leak, earlier feeding, reduced GER, better somatic growth and reduced incidence of ALTE/BRUE. Level of evidence: Level II (Treatment study/Randomized controlled trial).

Worth the Wait? The Impact of Timing of Repair of Esophageal Atresia With Tracheoesophageal Fistula on Outcomes

Short- and Long-Term Outcomes of Thoracoscopic and Open Repair For Esophageal Atresia and Tracheoesophageal Fistula

Outcomes of Thoracoscopy Versus Thoracotomy for Esophageal Atresia with Tracheoesophageal Fistula Repair

Outcomes of thoracoscopy versus thoracotomy for esophageal atresia with tracheoesophageal fistula repair: A PRISMA-compliant systematic review and meta-analysis.

Association of Operative Approach With Postoperative Outcomes in Neonates Undergoing Surgical Repair of Esophageal Atresia and Tracheoesophageal Fistula

Thoracoscopic Repair for Esophageal Pulmonary Fistula after Esophageal Atresia Repair

Repair of esophageal atresia with tracheoesophageal fistula via thoracotomy: a contemporary series

The Repair of Esophageal Atresia and Major Complications— a Systematic Review and Our Experience in Dealing with the Tracheoesophageal Fistula

Repair of Type C Tracheo-esophageal Fistula/Esophageal Atresia With or Without Trans Anastomotic Tube: A Pilot Randomized Controlled Trial

Clinical outcomes following implementation of a management bundle for esophageal atresia with distal tracheoesophageal fistula

Risk Factors for Recurrent Tracheoesophageal Fistula After Gross Type C Esophageal Atresia Repair

Esophagitis, treatment outcomes, and long‐term follow‐up in children with esophageal atresia

Prognostic Factors of Survival Rate after Repair of Esophageal Atresia (EA) And/or Tracheoesophageal Fistula (TEF)

Management and Outcomes of Esophageal Atresia With or Without Tracheo-Esophageal Fistula Over 15 Years in South Africa

Thoracoscopic Repair of Congenital Esophageal Atresia in Neonates: a Report of 69 Cases

Anastomotic Leak and its Implications: A Multicenter Analysis of "Type C" Esophageal Atresia / Tracheo-esophageal fistula (EA/TEF)

The Diagnosis and Treatment of Esophageal Fistula after Primary Operation of Congenital Esophageal Atresia

Management of Recurrent Tracheoesophageal Fistula after Esophageal Atresia and Follow-Up.

Repair of Tracheoesophageal Fistula via Median Sternotomy Approach

139. DOES POSTOPERATIVE NON-INVASIVE VENTILATION INCREASE THE RISK FOR COMPLICATIONS IN CHILDREN POST-REPAIR OF ESOPHAGEAL ATRESIA?

Post-esophageal atresia repair double acquired tracheoesophageal fistulas treated successfully by gastric transposition: a case report